Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine for constipation in palliative care patients taking anticholinergic medications
ACTRN12614000540617Phase 2Recruiting
- Sponsor
- Calvary Mater Newcastle
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pyridostigmine in constipation, sponsored by Calvary Mater Newcastle. Primary endpoint: Safety feasibility for phase III study. Started Jul 2014; status: recruiting.
02
Drugs
pyridostigmine
03
Conditions
constipation
Beyond the preview
Go deeper on ACTRN12614000540617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000540617.